MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 104 filers reported holding MAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,490,547 | -32.3% | 6,887,996 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $31,763,185 | -8.6% | 6,920,084 | -1.4% | 0.00% | 0.0% |
| Q1 2023 | $34,752,273 | -6.6% | 7,020,661 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $37,210,348 | -11.2% | 6,815,082 | +5.7% | 0.00% | 0.0% |
| Q3 2022 | $41,912,000 | +56.5% | 6,447,943 | +13.9% | 0.00% | 0.0% |
| Q2 2022 | $26,787,000 | -29.6% | 5,663,419 | +4.0% | 0.00% | 0.0% |
| Q1 2022 | $38,052,000 | -28.4% | 5,443,837 | +4.4% | 0.00% | 0.0% |
| Q4 2021 | $53,135,000 | +541.0% | 5,214,464 | +668.1% | 0.00% | – |
| Q3 2021 | $8,290,000 | – | 678,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |